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Abstract 
We report the case of an 86-year-old man with acute left shoulder pain, followed by left 
limb monoparesis and a herpetic rash on the left upper limb and thoracic region. This 
situation presented a diagnostic challenge because of the simultaneity of symptoms 
attributable to Parsonage-Turner syndrome and herpes zoster neuropathy. A detailed 
clinical history, physical examination and electroneuromyography were essential to 
distinguish the neurological structures involved and to ascertain the diagnosis. 
 
Introduction 
Parsonage-Turner syndrome (PTS), also known as neuralgic amyotrophy or acute 
brachial plexus neuritis, is a disorder characterized by the sudden appearance of severe 
shoulder pain, usually unilateral, followed a few days to a week later by progressive motor 
weakness. At times, some dysesthesiae and numbness may coexist. The key to establishing 
the diagnosis is the sequence of symptoms and confirmation by electroneuromyography. 
We report the case of an 86-year-old man referred to our internal medicine 
department for severe left shoulder pain. In this patient, diagnosis was complicated by the 
occurrence of herpetic lesions on the upper left arm and thoracic region. 
Case Presentation 
An 86-year-old right-handed man presented to his general practitioner with complaints of acute left 
shoulder pain that awoke him one night. There was no history of previous shoulder trauma. The patient 
had suffered from a low-grade stage IV non-Hodgkin B-cell lymphoma 4 years earlier that was treated 
with rituximab chemotherapy alone without radiotherapy, which led to remission. An ultrasound of his Case Rep Neurol 2011;3:165–171 
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shoulder revealed a scapulohumeral periarthritis. An intra-articular corticoid infiltration was performed 
on an outpatient basis. He was referred to our department 7 days after the onset of the symptoms 
because of persistent shoulder pain. 
At admission, the patient presented a hypertensive crisis that was attributed to the severe shoulder 
pain and was managed with nitroglycerin and calcium-channel blockers. The patient denied any neck 
pain, headache, fever, chills or weight loss. Neurologic examination was normal at the time, with 
preserved sensory and motor functions of the left arm. The patient was oriented and showed no signs of 
meningeal irritation. Routine laboratory tests were normal. 
Two days following hospital admission, i.e. 9 days after the beginning of the left shoulder pain, he 
presented a vesicular rash over the left D1 and D2 dermatomes. An immunofluorescence test of a skin 
sample was positive for herpes varicella-zoster virus. A 10-day treatment of intravenous acyclovir in 
conjunction with prednisone was started. Pain was managed with paracetamol, morphine, pregabalin 
and physiotherapy. Two days after the vesicular eruption, i.e. 11 days after the beginning of the shoulder 
pain, he developed a marked weakness of the left arm. This weakness was severe on elbow flexion (1/5), 
shoulder abduction (1/5) and arm external rotation (1/5), whereas elbow extension and handgrip 
remained normal (5/5). There was no sensory loss. Deep left bicipital tendon reflex was absent. 
Needle electromyography (table 1) showed evidence of partial denervation of the left biceps, 
brachioradialis and deltoid muscles, consistent with peripheral motor nerve involvement of the C5 and 
C6 myotomes. As the rhomboid and serratus anterior muscles were not affected, it is possible that the 
denervation was related to motor axonal lesions within the upper trunk of the brachial plexus. 
Neurography showed responses of small but symmetric amplitudes, in particular for the sensory nerve 
conductions (table 2). A CT scan of the cervical spine showed mild cervical osteoarthritis without spinal 
compromise. A thoracic CT scan showed no adenopathy or mass associated with the lymphoma and 
ruled out a local root or plexus compression. MRI of the brain showed a global cerebral atrophy that was 
attributed to the age of the patient. MRI of the brachial plexus was not performed. 
The diagnosis of troncular, motor neurological lesions due to herpes zoster infection was initially 
suspected. However, the symptoms, their timing, as well as the neurological territories affected – upper 
brachial plexus for the motor deficit, dermatomes of the lower brachial plexus D1 and upper thoracic 
region D2 for the vesicular rash – casted doubts on this hypothesis. The symptoms seemed more 
probably related to PTS rather than to herpes zoster infection of the upper left arm. The clinical 
presentation, the results of the CT scan of the cervical and thoracic spine, and the motor-evoked 
potentials made cervical myelopathy unlikely. 
Over the course of the following days, the weakness persisted. The patient was transferred to a 
rehabilitation unit to continue physiotherapy. A second electroneuromyography was performed 24 days 
after the first, i.e. 6 weeks after the onset of the shoulder pain (tables 1, 2). It showed signs of severe 
denervation of the left biceps, deltoid, supraspinatus and brachioradialis muscles. The neurological 
findings and normal transcranial motor-evoked potentials were not suggestive of cervical myelopathy. 
Subsequently, the patient experienced a general deterioration and sepsis caused by Staphylococcus 
aureus infection. Despite antibiotic therapy, he died 2 months after admission to the rehabilitation unit, 
i.e. 3 months after the onset of the symptoms. 
Discussion 
The clinical presentation of a herpetic eruption and a motor deficit in the same limb 
may lead to diagnostic pitfalls. The first diagnosis that may come to mind in this situation 
is a motor monoparesis due to herpes zoster infection. However, this early impression 
may be challenged in this situation. Our hypothesis is that the patient presented two 
different successive conditions. First, left shoulder pain followed 11 days later by left arm 
weakness, possibly related to PTS, then a vesicular eruption of the left arm caused by 
varicella-zoster virus reactivation, as confirmed by immunofluorescence. The time 
elapsed between the eruption and the weakness, only 2 days, is rather short to be Case Rep Neurol 2011;3:165–171 
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explained by a herpes zoster motor monoparesis. Moreover, the distance between the 
lesions of the sensory ganglions causing the skin vesicular rash (dermatomes D1 and D2) 
and the motor axonal lesions causing denervation within the upper myotomes of the 
brachial plexus (C5–C6) also makes the diagnosis of herpes zoster monoparesis unlikely. 
Sensory findings, if present, are usually much less prominent than motor deficits in PTS. 
The contrary is true in zoster neuropathies, in which sensory lesions are usual and motor 
deficits rare (with the notable exception of zoster facial palsy). 
Although all weak muscles observed to exhibit denervation belonged to the C5 and C6 
myotomes, a radiculopathy appears unlikely in this patient since (1) it should have very 
seriously affected both C5 and C6 roots simultaneously in order to explain the complete 
or subcomplete denervation of the muscles of the anterior arm, and, in such a case, it 
would then probably have affected the spinatus and brachioradialis muscles with a similar 
severity; (2) a mechanical lesion of the roots would have caused sensory symptoms in the 
C5 and C6 dermatomes; (3) denervation would have concerned the rhomboid and 
serratus muscles. The severe, incomplete axonal lesion was thus more likely localized 
within the upper trunk. Symmetrical sensory neurography (from the C6 dermatome; digit 
I) without clinical sensory loss (in particular in the C5–C6 dermatomes), points to a 
lesion that essentially affected the motor axons. This is in line with the possibility of a 
selective targeted immunologic lesion, and thus in good agreement with the suspected 
causal mechanism of PTS. We hypothesize, therefore, that the development of herpes 
zoster was a consecutive phenomenon, possibly favored by the PTS itself, the lymphoma 
and the intra-articular corticoid infiltration. 
PTS is a neuritis of unknown cause affecting the brachial plexus with an overall 
incidence of 1.64 cases per 100,000 individuals [1–4]. The classic description of PTS is a 
condition in which the patient first develops an abrupt, severe and constant unilateral 
shoulder pain that can extend proximally to the neck but also distally to the upper arm, 
forearm and hand. Pain lasts from a few hours to several weeks, with an average duration 
of 4 weeks. The weakness appears within 24 h of the onset of pain in approximately one-
third of patients but can take up to 4 weeks to occur [5]. A sensory deficit may also occur 
but its prevalence varies, depending on studies, from 66% to only a minority of patients 
[6–8].
 The upper trunk of the brachial plexus is the most frequent site of the lesion [6]. 
Clinical observation and electromyogram studies suggest that the lesions are often 
multifocal within the plexus or in the individual branches [9, 10]. 
Electroneuromyography is helpful to confirm the diagnosis, to rule out other possible 
causes of painful weakness of the upper limb (radiculopathies, thoracic outlet syndrome 
or mononeuropathies), and to define the prognosis. Frequently, the syndrome is initially 
mistaken for an arthropathy of the shoulder, as was the case in this patient. Blood and 
cerebrospinal fluid analyses are generally unhelpful. A chest radiograph or CT scan can be 
performed if there is any suspicion of malignancy. 
The treatment is based on pain management, NSAIDs, prednisolone and neuroleptics 
[11, 12].
 This condition generally carries a good prognosis, as about 75% of all patients 
recover completely within 2 years, and 89% by the end of the third year. Patients with 
predominantly lower plexus involvement have a slower recovery. The rate of recurrence 
varies among studies, from 5 to 26%, and the second episode typically turns out less 
severe [4]. Case Rep Neurol 2011;3:165–171 
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Herpes zoster can cause segmental paresis with a reported incidence of 3–5% of limb 
weakness [13]. The paresis affecting the same zone typically occurs 2–3 weeks after the 
herpetic rash. The prognosis of functional recovery with zoster paresis is good, with a 
complete or partial recovery reported in 75% of patients within 1 or 2 years [14]. The 
administration of antiviral therapy may have a positive effect on the course of the paresis. 
In both PTS and zoster paresis, prevention of muscle contracture and atrophy by 
physiotherapy is an important part of the treatment [15]. 
The etiology of PTS is unclear but many possible promoting factors have been 
proposed including trauma, recent surgery, infection, heavy exercise, immunization and 
autoimmune conditions. Although the literature reports a direct relationship between 
herpes zoster and plexus neuritis [6, 15], the causal relationship between this viral 
infection and PTS is not yet established. The hypothesis that a number of neuralgic 
amyotrophy cases may be caused by unrecognized herpes neuritis is tenable, in particular 
in case of zoster sine herpete. 
Conclusion 
PTS is a diagnostic challenge because it may mimic several conditions causing pain 
and weakness around the shoulder, such as rotator cuff tears, acute calcifying tendinitis, 
impingement syndromes, cervical radiculopathy, tumors of the brachial plexus and spinal 
cord and compressive nerve injuries. In the reported case, the presence of concomitant 
shingles was a pitfall, with the potential to mask the underlying PTS and to lead to a 
misdiagnosis of herpetic brachial plexopathy. A detailed clinical history and physical 
examination, as well as the help of electroneuromyography were essential to distinguish 
the neurological structures involved and to ascertain the correct diagnosis. 
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Table 1. Needle electromyography 
  Fib.  PSW  Fasc.  Description and voluntary activity 
Days 12 and 14 (left side)         
Supraspinatus  +/–  +/–  0  Simple recording –1 MUP firing at 25 Hz 
Infraspinatus  +  +/–  0  Increased insertional activity; poor intermediate pattern 
Deltoid ++  +/–  0  Intermediate  pattern 
Biceps  brachii  + + 0 No  voluntary  activity 
Brachioradialis  + + 0 Intermediate  pattern 
Rhomboid major  //  //  //  Clinically normal; no needle EMG 
Day 38 (left side)         
Rhomboid major  0  0  0  Interference pattern; normal size MUPs 
Serratus anterior (2 sites)  0  0  0  Interference pattern; normal size MUPs 
Supra spinatus  ++  ++  0  Intermediate pattern; high frequencies (25 Hz or more audible) 
Deltoid  +++  +++  0  Simple recording; 1 MUP firing at >25Hz 
Biceps brachii  ++++  +++  0  Increased insertional activity; no voluntary activity 
Brachialis  ++++  +++  0  No voluntary activity 
Brachioradialis  ++  ++  0  Intermediate pattern with frequencies >25 Hz 
Fib. = Fibrillation; PSW = positive sharp wave; Fasc. = fasciculation; MUP = motor unit potential. 
0 = No spontaneous activity; +/– = 1 Fib. (or PSW) in 1 region of the muscle; + = 2 Fibs. (or PSWs) in 2 different regions;  
++ = >2 Fibs. (or PSWs) in several regions; +++ = abundant Fibs. (or PSWs) in most regions; ++++ = abundant Fibs. (or PSWs) 
in all regions with no voluntary activity and no response to electrical nerve stimulation; // = not studied. 
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Table 2. Nerve conduction studies 
Sensory Latency 
ms 
Amplitude 
μV 
Duration 
ms 
Area 
μV × ms 
Distance 
mm 
Conduction 
velocity 
m/s 
Temperature 
°C 
Days 12 and 14              
Median              
Wrist–digit II L  3.0  08 1.9  5  142  48  34.1 
Wrist–digit II R  2.7  06 1.8  6  131  49  33.0 
Palm–digit II R  1.5  09 1.5  4  076 51  33.0 
Wrist–digit I L  2.3  10  2.2  5  105  46  34.2 
Wrist–digit I R  1.8  11  1.6  6  083 45  33.0 
Radial              
Wrist–digit I L  2.0  02 1.2  2  100  50  33.9 
Wrist–digit I R  1.8  02 1.1  2  085 46  33.0 
Ulnar              
Wrist–digit V R  2.3  10  1.7  6  117  52  33.0 
Day 38              
Median              
Wrist–digit II L  2.7  08 2.1  4  135  50  31.9 
Ulnar              
Wrist–digit V L  2.4  09 2.1  6  125  52  33.0 
Motor Latency 
ms 
Amplitude 
mV 
Duration 
ms 
Area 
mV × ms 
Distance 
mm 
Conduction 
velocity 
m/s 
CMCT (ms) 
Ulnar              
ADM L–wrist  02.5 6.8  07.2 21.4  055    
Wrist–elbow below  06.6 6.8  07.5 20.7  220  54   
Elbow below–above  08.2 6.4  07.9 21.8  070 44   
Elbow above–axilla  12.0  6.0  07.2 19.6       
Axilla–elbow 15.1  5.8  07.2 19.6       
F waves ADM L–Wrist  29.8             
Median              
ADM–elbow  09.4 (+)0.1 11.1  (+)0.6       
MEP (TMS)               
ADM L–cortex R  22.0  4.5  09.5 18.9      6.3 
Sensory neurography is antidromic; for amplitude, peak-to-peak amplitude was measured; for duration, negative take-off to 
positive peak duration was measured. Motor neurography: for the compound muscle action potential, amplitude, duration and 
area of the negative peak were measured. ADM = Abductor digiti minimi; MEP = motor-evoked potential; TMS = transcranial 
magnetic stimulation; CMCT = central motor conduction time; (+) = positive peak. 
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